SM 10661
Alternative Names: SM-10661Latest Information Update: 30 Aug 2007
At a glance
- Originator Sumitomo Pharmaceuticals
- Class Antiasthmatics; Antithrombotics
- Mechanism of Action Platelet activating factor inhibitors; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Gastroduodenal disorders
Most Recent Events
- 11 Aug 1997 No-Development-Reported for Asthma in Japan (Unknown route)
- 11 Aug 1997 No-Development-Reported for Gastroduodenal disorders in Japan (Unknown route)
- 26 Nov 1996 Preclinical development for Asthma in Japan (Unknown route)